Diagnostics & Research
Healthcare32 US-listed companies tracked
Diagnostics & Research companies develop and commercialize lab tests, diagnostic equipment, and research services for hospitals and healthcare systems. Key sensitivities include reimbursement pressures from insurers and Medicare, clinical adoption barriers requiring FDA approval and evidence generation, and competition from larger integrated healthcare companies. TrendMatrix ranks 25 US-listed Diagnostics & Research stocks by 10-dimension quantitative score, refreshed every 5 minutes during market hours with a full reanalysis nightly.
Ranked stocks
| # | Symbol | Score | Verdict | Price | Upside |
|---|---|---|---|---|---|
| 1 | VCYT | 6.2 | Hold | $44.39 | +14.5% |
| 2 | CSTL | 6.2 | Sell | $33.80 | +16.4% |
| 3 | MEDP | 6.1 | Buy Wait | $628.60 | -17.5% |
| 4 | BLLN | 6.1 | Hold | $102.73 | +9.2% |
| 5 | DHR | 6.1 | Hold | $231.50 | -5.1% |
| 6 | CDNA | 6.1 | Sell | $66.67 | -19.5% |
| 7 | NEO | 6.0 | Sell | $17.25 | +10.2% |
| 8 | SHC | 5.9 | Sell | $18.07 | +8.9% |
| 9 | IDXX | 5.8 | Buy Wait | $547.18 | +11.5% |
| 10 | WAT | 5.7 | Hold | $444.15 | -6.8% |
| 11 | FRNM | 5.7 | Sell | $12.29 | +27.5% |
| 12 | LH | 5.6 | Hold | $325.07 | -4.4% |
| 13 | DGX | 5.5 | Sell | $239.15 | -6.4% |
| 14 | OPK | 5.5 | Sell | $1.61 | +131.0% |
| 15 | RDNT | 5.5 | Sell | $70.41 | +16.9% |
| 16 | QGEN | 5.4 | Hold | $46.17 | -6.2% |
| 17 | MTD | 5.4 | Sell | $1639.04 | -18.8% |
| 18 | TMO | 5.3 | Hold | $696.49 | -11.3% |
| 19 | WGS | 5.3 | Sell | $70.22 | +15.8% |
| 20 | A | 5.2 | Hold | $175.55 | -7.6% |
| 21 | GH | 5.2 | Sell | $165.88 | +9.4% |
| 22 | IQV | 5.1 | Sell | $271.04 | -1.4% |
| 23 | NTRA | 5.1 | Sell | $404.79 | -10.2% |
| 24 | ADPT | 4.9 | Sell | $25.58 | +1.4% |
| 25 | PSNL | 4.9 | Sell | $15.93 | -19.1% |
| 26 | RVTY | 4.8 | Hold | $154.71 | -14.2% |
| 27 | GRAL | 4.8 | Sell | $135.46 | -15.7% |
| 28 | FLGT | 4.7 | Sell | $21.34 | -24.3% |
| 29 | CRL | 4.5 | Sell | $306.24 | -7.3% |
| 30 | ICLR | 4.5 | Sell | $175.13 | -4.5% |
| 31 | ILMN | 4.4 | Hold | $267.93 | -19.0% |
| 32 | MYGN | 4.2 | Hold | $4.35 | -17.8% |